Stock Futures Move Higher as Traders Await Today’s Fed Rate Policy Decision
The gains have come while traders await the conclusion of the final Fed meeting of 2023.
The gains have come while traders await the conclusion of the final Fed meeting of 2023.
The updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential to evade immunity conferred by earlier versions of the vaccine.
Covid vaccine stocks, including Moderna, BioNTech, and Novavax have all closed higher as new vaccinations and treatments roll out.
Google Cloud’s AI-enabled ‘Target and Lead Identification’ and ‘Multiomics’ Suites are set to improve drug discovery and precision medicine.
Affected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report.
Pfizer has been on an acquisition spree as it seeks to cushion the impact of a projected $17 billion revenue drop by 2030.
As the year winds down and we anticipate 2023, Coinspeaker has put together a recap of some of the most newsworthy events of 2022.
The dwindling fortunes of Facebook has seen parent company Meta lose its position as one of the US top 20 companies ranked by market cap.
Johnson & Johnson saw a better-than-expected in the third quarter according to its Q3 2022 report. However, JNJ may cut jobs soon.
Both COVID-19 sales and Paxlovid contributed immensely to the impressive financial report Pfizer announced for Q2 2022.